About Dasanat Dasatinib Tablet
Experience the latest innovation in anticancer therapy with Dasanat Dasatinib Tablet, a trending and eminent prescription medicine for adults. Each valiant white to off-white tablet contains 50mg of Dasatinib-known for its targeted kinase inhibition. Dasanat champions the fight against Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), offering special hope for patients. Supplied as a strip of 60 tablets, its controlled origin from India ensures uncompromising quality. To be dispensed only under an oncologist's guidance, Dasanat is the preferred choice among elite distributors, suppliers, and traders across India.
Targeted Application & Specialized Use
Dasanat Dasatinib Tablet is designed for oral administration and is used specifically for adults diagnosed with CML and Ph+ ALL. The site of application is systemic, acting directly in the bloodstream to inhibit targeted kinases. Oncologists prescribe Dasanat as a key part of therapy for conditions requiring precision intervention. Its general use centers on treating certain types of leukemia, ensuring focused results for patients in need of advanced oncologic care.
Quotation, Payment, and Delivery Terms
Payment terms for Dasanat Dasatinib Tablet are typically provided upon receiving a quotation from authorized suppliers. Once the order is finalized, tablets are handed over securely, ensuring compliance with all regulatory protocols. Delivery times may vary but are prioritized for timely handover to healthcare providers. The main export markets include India and neighboring regions, with distributors and traders facilitating smooth transitions from quotation to delivery within the specified timeline.
FAQ's of Dasanat Dasatinib Tablet:
Q: How should Dasanat Dasatinib Tablet be stored before use?
A: Dasanat Dasatinib Tablet should be kept in its original packaging and stored in a dry, cool place until administration to maintain efficacy and stability.
Q: What is the primary indication for prescribing Dasanat Dasatinib Tablet?
A: It is primarily indicated for the treatment of adults with Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
Q: When should Dasanat Dasatinib Tablet be administered?
A: This medicine should be administered orally as prescribed by an oncologist, according to an established dosage schedule tailored to the patient's condition.
Q: Where can patients obtain Dasanat Dasatinib Tablet?
A: Dasanat Dasatinib Tablet can only be purchased at licensed retail pharmacies upon presentation of a valid prescription from an oncologist.
Q: What is the process for obtaining a quotation and delivery of Dasanat Dasatinib Tablet?
A: Patients or healthcare facilities must contact authorized distributors or suppliers to request a quotation. Upon agreement, tablets are promptly handed over and delivered in compliance with regulatory standards.
Q: What benefits does Dasanat Dasatinib Tablet provide over conventional chemotherapy?
A: As a targeted kinase inhibitor, Dasanat offers a specialized approach to treating leukemia, often resulting in improved outcomes and fewer side effects compared to some traditional chemotherapy regimens.